These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5854944)

  • 1. [Comparative study of electrocardiographic changes determined by treatment with tri- and pentavalent antimony].
    de Lacerda Júnior FS; Ferminiani H; da Mota CC; Baranski C
    Rev Inst Med Trop Sao Paulo; 1965; 7(4):210-7. PubMed ID: 5854944
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrocardiographic modifications from antimony in a group of Yemenite patients affected by schistosomiasis].
    Parrinello A
    Rass Clin Ter; 1966; 65(2):121-5. PubMed ID: 5943145
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: promising but inconclusive evidence of superiority, compared with antimony monotherapy.
    Ojha RP; Cervantes D; Fischbach LA
    Clin Infect Dis; 2007 Oct; 45(8):1104; author reply 1005-6. PubMed ID: 17879933
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of electrocardiographic changes due to antimony and Ciba 32644-Ba].
    da Silva JA; de Souza e Silva NA; Nogueira Filho LN; Grinberg M; Fraga Filho C
    Hospital (Rio J); 1967 Nov; 72(5):1455-63. PubMed ID: 5307819
    [No Abstract]   [Full Text] [Related]  

  • 5. [ELECTROCARDIOGRAPHIC CHANGES OBSERVED IN PATIENTS SUBJECTED TO ANTIMONY THERAPY].
    GERMINIANI H; SILVEIRADAMOTA CC; DE LACERDA FS; BARANSKI MC
    Arq Bras Cardiol; 1963 Oct; 16():299-310. PubMed ID: 14118597
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of Ciba 32644-Ba and trivalent antimony on the ECG].
    da Ferreira FS; Pinto PM
    Acta Trop Suppl; 1966; 9():265-8. PubMed ID: 5219459
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electrocardiographic alterations caused by trivalent antimonials in the treatment of patients with schistosomiasis].
    TEIXEIRA R; PRATA A
    Hospital (Rio J); 1960 Nov; 58():915-9. PubMed ID: 13775752
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.
    Goyeneche-Patino DA; Valderrama L; Walker J; Saravia NG
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4503-6. PubMed ID: 18824610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on the electrocardiogram of potassium antimony tartrate (tartar emetic) in patients treated for schistosomiasis.
    ABDALLA A; BADRAN A
    J Egypt Med Assoc; 1962; 44():767-71. PubMed ID: 14036540
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on antibilharzial drugs. XXXI. Resin antimony tartrate: its preparation and experimental therapy].
    Zeng YL; Lu ZX
    Yao Xue Xue Bao; 1965 Nov; 12(11):727-33. PubMed ID: 5899004
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxicity of pentavalent antimony.
    Singh S; Sundar S
    J Assoc Physicians India; 1994 Sep; 42(9):755. PubMed ID: 7741886
    [No Abstract]   [Full Text] [Related]  

  • 12. American cutaneous leishmaniasis: disappearance of amastigotes from lesions during antimonial therapy.
    Mayrink W; Raso P; Melo MN; Michalick MS; Magalhães PA; Williams P; da Costa CA; Dias M
    Rev Inst Med Trop Sao Paulo; 1983; 25(6):265-9. PubMed ID: 6672988
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of antibilharzial antimonial compounds on the percentage oxygen saturation of blood.
    Abdel-Meguid M; Habib YA; Abdallah A; Sajf M
    J Egypt Med Assoc; 1967; 50(6):369-74. PubMed ID: 5592865
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of schistosomicidals on lung ventilation in bilharzial cases.
    Mousa AH; El-Garem A; El-Hawey AM; Abdel-Latif EA
    J Egypt Med Assoc; 1968; 51(9):765-81. PubMed ID: 5711101
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic trial of selected organophosphates against Schistosoma mansoni infections in mice.
    Campbell WC; Cuckler AC
    J Parasitol; 1966 Aug; 52(4):827-8. PubMed ID: 5969133
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of natural antimony resistance in Leishmania donovani isolates.
    Mittal MK; Rai S; Ashutosh ; Ravinder ; Gupta S; Sundar S; Goyal N
    Am J Trop Med Hyg; 2007 Apr; 76(4):681-8. PubMed ID: 17426170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of a new synthetic chemical compound with expected antibilharzial properties.
    Galal EE; Nasr A; Shinawy AM; Baraka Y; Mahmoud MA; Azzam B; el Far N
    J Egypt Med Assoc; 1965; 48():Suppl:127-51. PubMed ID: 5873669
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimony-based antileishmanial compounds prolong the cardiac action potential by an increase in cardiac calcium currents.
    Kuryshev YA; Wang L; Wible BA; Wan X; Ficker E
    Mol Pharmacol; 2006 Apr; 69(4):1216-25. PubMed ID: 16418337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic changes occuring with trivalent antimony compounds during therapy of schistosomiasis.
    LAU FY
    Calif Med; 1953 Aug; 79(2):114-7. PubMed ID: 13067028
    [No Abstract]   [Full Text] [Related]  

  • 20. Complexation of antimony (Sb(V)) with guanosine 5'-monophosphate and guanosine 5'-diphospho-D-mannose: formation of both mono- and bis-adducts.
    Chai Y; Yan S; Wong IL; Chow LM; Sun H
    J Inorg Biochem; 2005 Dec; 99(12):2257-63. PubMed ID: 16214217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.